SSSS Stock Analysis: SuRo Capital | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 327m USD | 12M Return: 53.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.46M
Qual. Beats: 0
Rev. Trend: 82.0%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
SuRo Capital Corp. (NASDAQ: SSSS) is a publicly traded investment company that operates as both a business development company (BDC) and a venture capital firm. Founded in 2010 and headquartered in San Francisco, the company went public in April 2011 and is classified within the GICS Asset Management & Custody Banks sub-industry.
The firm provides growth capital, mezzanine financing, and secondary investments, primarily targeting late-stage and venture capital-backed private companies. It focuses on minority equity stakes across the energy, consumer, technology, media, and communication sectors, with a geographic emphasis on the United States and Canada.
As a BDC, SuRo Capital is regulated under the Investment Company Act of 1940, a structure that typically requires the distribution of the majority of taxable income to shareholders. Like many listed BDCs and closed-end investment vehicles, its shares tend to trade at a price relative to the net asset value (NAV) of its underlying private holdings.
- Tech portfolio markdowns pressure NAV per share and valuation
- Discount to NAV drives opportunistic share buyback activity
- Recovering IPO market unlocks portfolio company realization opportunities
| Net Income: 205.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 9.79 > 1.0 |
| NWC/Revenue: 63.55% < 20% (prev 231.5%; Δ -167.9% < -1%) |
| CFO/TA -0.01 > 3% & CFO -2.64m > Net Income 205.3m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 23.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (30.2m) vs 12m ago 27.95% < -2% |
| Gross Margin: 92.27% > 18% (prev 24.78%; Δ 67.49% > 0.5%) |
| Asset Turnover: 19.63% > 50% (prev 2.81%; Δ 16.83% > 0%) |
| Interest Coverage Ratio: 40.93 > 6 (EBIT TTM 206.5m / Interest Expense TTM 5.05m) |
| A: 0.10 (Total Current Assets 43.3m - Total Current Liabilities 1.84m) / Total Assets 433.3m |
| B: -0.02 (Retained Earnings -7.95m / Total Assets 433.3m) |
| C: 0.62 (EBIT TTM 206.5m / Avg Total Assets 332.5m) |
| D: 5.04 (Book Value of Equity 361.6m / Total Liabilities 71.7m) |
| Altman-Z'' = 10.04 = AAA |
As of July 08, 2026, the stock is trading at USD 11.65 with a total of 301,368 shares traded. Over the past week, the price has changed by -1.69%, over one month by -15.95%, over three months by -0.60% and over the past year by +53.17%.
Current recommended Stop Loss: 10.90 (which is 6.4% or 1.3 ATR below the current price).
SuRo Capital has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy SSSS.
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 16.4 | 40.3% |
P/E Trailing = 1.794
P/E Forward = 0.7631
P/S = 170.345
P/B = 0.8804
Revenue TTM = 65.3m USD
EBIT TTM = 206.5m USD
EBITDA TTM = -187950b USD
Long Term Debt = unknown (0.0)
Short Term Debt = 34191b USD (from shortTermDebt, last quarter)
Debt = 69.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 26.6m USD (calculated: Debt 69.9m - CCE 43.3m)
Enterprise Value = 353.5m USD (326.9m + Debt 69.9m - CCE 43.3m)
Interest Coverage Ratio = 40.93 (Ebit TTM 206.5m / Interest Expense TTM 5.05m)
EV/FCF = -133.9x (Enterprise Value 353.5m / FCF TTM -2.64m)
FCF Yield = -0.75% (FCF TTM -2.64m / Enterprise Value 353.5m)
FCF Margin = -4.05% (FCF TTM -2.64m / Revenue TTM 65.3m)
Net Margin = 314.5% (Net Income TTM 205.3m / Revenue TTM 65.3m)
Gross Margin = 92.27% ((Revenue TTM 65.3m - Cost of Revenue TTM 5.05m) / Revenue TTM)
Gross Margin QoQ = 24.98% (prev none%)
Tobins Q-Ratio = 0.82 (Enterprise Value 353.5m / Total Assets 433.3m)
Interest Expense / Debt = 7.22% (Interest Expense 5.05m / Debt 69.9m)
Taxrate = 0.04% (57.6k / 155.7m)
NOPAT = 206.4m (EBIT 206.5m * (1 - 0.04%))
Current Ratio = 23.60 (Total Current Assets 43.3m / Total Current Liabilities 1.84m)
Debt / Equity = 0.19 (Debt 69.9m / totalStockholderEquity, last quarter 361.6m)
Debt / EBITDA = -0.00 (negative EBITDA) (Net Debt 26.6m / EBITDA -187950b)
Debt / FCF = -10.06 (negative FCF - burning cash) (Net Debt 26.6m / FCF TTM -2.64m)
Total Stockholder Equity = 254.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 61.74% (Net Income 205.3m / Total Assets 433.3m)
RoE = 80.64% (Net Income TTM 205.3m / Total Stockholder Equity 254.5m)
RoCE = 81.14% (EBIT 206.5m / Capital Employed (Equity 254.5m + L.T.Debt 0.0))
RoIC = 0.00% (NOPAT 206.4m / Invested Capital 34191b)
WACC = 9.68% (E(326.9m)/V(396.8m) * Re(10.21%) + D(69.9m)/V(396.8m) * Rd(7.22%) * (1-Tc(0.00)))
Discount Rate = 10.21% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 51.11 | Cagr: 8.23%
[DCF] Fair Price = unknown (Cash Flow -2.64m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.01 | # QB: 0
Revenue Correlation: 82.03 | Revenue CAGR: 208.6% | SUE: 0.05 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.13 | Chg30d=+16.13% | Revisions=-25% | Analysts=2
EPS next Quarter (2026-09-30): EPS=-0.13 | Chg30d=+18.75% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=4.76 | Chg30d=+816.54% | Revisions=+0% | GrowthEPS=+167.7% | GrowthRev=+30.8%
EPS next Year (2027-12-31): EPS=-0.56 | Chg30d=+22.92% | Revisions=-25% | GrowthEPS=-8.3% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: -38% (up=1, down=4)